Publication | Open Access

Adavosertib plus gemcitabine for platinum-resistant or platinum-refractory recurrent ovarian cancer: a double-blind, randomised, placebo-controlled, phase 2 trial

MedicineMetronomic TherapyClinical TrialsGynecologyPharmacotherapyCancer TreatmentOncologyRadiation OncologyOvarian CancerHealth Sciences